Sponsor:
Innovus Pharmaceuticals, Inc.
Code:
NCT03767504
Conditions
Healthy Volunteers
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Accepted
Interventions
Thymol
Brief summary:
Conditions
Healthy Volunteers
Study ID
NCT03767504
Start date
Nov 13, 2018
Status verified date
Dec, 2018
Completion date
Feb 28, 2019
Anticipated
Primary completion date
Feb 13, 2019
Anticipated
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Accepted
Enrollment
20 participants
Anticipated
Intervention Model
Single group
Primary purpose
Other
Arms
experimental: Musclin
Interventions
Thymol
Primary outcome measure
Locations
Palm Beach Research Center
Recruiting
West Palm Beach, Florida, United States, 33409
Contacts
Principal Investigator:
Mira Baron, MD
Sponsor
Innovus Pharmaceuticals, Inc.
Last update posted
Dec 6, 2018
Last verified
Dec, 2018
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Innovus Pharmaceuticals, Inc. on 2018-12-06.